About PRIME
Advertise With Us
Contact Us

Home
Digital Issue
Categories
Features
News
Sign Up
Login

Select Page

Enjoy your September/October 2019 issue of PRIME

VOL. 9 ISSUE 5

Share:

PreviousGroundbreaking Event to Address Asia-Pacific’s Growing Beauty Sector—Your Window to the World’s Fastest Growing Beauty Market

NextU.SK Under Skin Launches in the United States with Four New Products

Related Posts

Galderma Granted FDA Approval for New Indication for Restylane® Lyft

Galderma Granted FDA Approval for New Indication for Restylane® Lyft

July 29, 2015

Customizable Skin Treatments Address Patient-Specific Concerns

Customizable Skin Treatments Address Patient-Specific Concerns

December 5, 2018

Novartis receives FDA approval of Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600-mutant melanoma

Novartis receives FDA approval of Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600-mutant melanoma

May 14, 2018

Scientists May Have Discovered A ‘Holy Grail’ For Healing Scars

Scientists May Have Discovered A ‘Holy Grail’ For Healing Scars

June 2, 2021

Search

Search for:

Login Status

Username or Email

Password

Forgot? Register

January/February 2026 Issue

Advertisement

Upcoming Events

No events are found.

Categories

Injectables
Dermatology
Anti-ageing
Body Contouring
Invasive treatments
Case Study
Practice Management
Sponsored
Industry Insider
Company Profile
PRIME People
Meeting reviews
Commentary

Designed by Elegant Themes | Powered by WordPress

Contact Us
Editorial Board
Terms & Conditions
Privacy Policy